A B S T R A C T We measured propionyl coenzyme A carboxylase (PCC) activity in extracts of skin fibroblasts and peripheral blood leukocytes from controls and obligate heterozygotes for PCC deficiency. 6 heterozygotes were from the pcc A complementation group; 12 were from the other major complementation group, designated pcc C. Mean PCC activity in fibroblast extracts from pcc A heterozygotes was 52% of that in controls, whereas mean PCC activity in pcc C heterozygotes was indistinguishable from that of controls. Similar results were obtained with extracts of peripheral blood leukocytes. In none of eight families (three pcc A and five pcc C) in which PCC activity was studied in both parents of an affected child were significant intrafamilial differences observed. The activities of two other mitochondrial enzymes (13-methylcrotonyl CoA carboxylase and glutamate dehydrogenase) were comparable in controls and both groups of heterozygotes. Whereas the data from pcc A heterozygotes are consistent with expected gene dosage effects, those from pcc C heterozygotes are not. Inasmuch as mammalian PCC is a large molecular weight tetramer, each protomer of which is probably composed of two nonidentical subunits, the latter results are most consistent with unbalanced rates of synthesis and(or) degradation of the two subunits in normal cells with compensatory balancing in pcc C heterozygotes.
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INTRODUCTION
Examination of all reported pedigrees containing at least 1 proband with propionic acidemia due to propionyl coenzyme A carboxylase (PCC)1 deficiency (1, 2) , as well as those from 16 (4) . Recently, Gravel et al. (5) demonstrated two major genetic complementation groups among fibroblast lines from PCC-deficient patients and designated them the pcc A and pcc C groups. To determine whether the previous disparate observations in heterozygotes for PCC deficiency reflect this genetic heterogeneity, we have measured PCC activity in extracts of cultured fibroblasts and peripheral blood leukocytes from 18 obligate heterozygotes for PCC deficiency. We find that each of six heterozygotes from the pcc A complementation group have PCC activities approximately half that of controls, whereas all 12 heterozygotes from the pcc C group have activities indistinguishable from controls.
METHODS
Cultured fibroblasts, initiated from skin biopsies, were propagated from 8 normal individuals, 10 children with PCC defi-ciency, and 18 parents and 1 sibling of PCC-deficient patients according to methods described previously (6) . Cell lines from each PCC-deficient proband were placed in either the pcc A or pcc C group by genetic complementation studies (5, 7) ; lines from their respective parents were assumed to belong to the proband's complementation group. When defined this way, 6 obligate heterozygotes (parents) and 1 possible heterozygote (a sibling) from 3 families were from the pcc A group, and 12 obligate heterozygotes from 7 families (parents) were from the pcc C group. Peripheral blood leukocytes, isolated from fresh heparinized blood as described previously (8) , were obtained from 10 normal adults, 4 pcc A obligate heterozygotes from 2 families, and 6 pcc C obligate heterozygotes from 3 families.
PCC activity was measured in freshly harvested extracts of cultured fibroblasts and leukocytes as described previously (6). ,f-Methylcrotonyl CoA carboxylase (J3MCC) activity was assayed in the same fibroblast extracts by substituting equimolar concentrations of f8-methylcrotonyl CoA for propionyl CoA in the incubation mixture (9) . Carboxylasespecific activities are expressed as picomole "4CO2 fixed per minute per milligram of extract protein. Glutamate dehydrogenase was measured by a modification of a procedure described previously (10) . Grouped enzyme activities are reported as the mean±1 SD. Protein was determined by a modification of the method described by Lowry et al. (11) .
RESULTS
Residual PCC activity in cells from probands. As noted in Fig. 1 , some PCC activity was detected in all fibroblast extracts from patients with PCC deficiency. This residual activity was comparable in cells from both complementation groups, and ranged from 0.5 to 8% of control activity (863±102 pmol/min per mg). The activity of,3MCC, another mitochondrial biotin-dependent enzyme, was very similar in extracts from pcc A homozygotes (267±27 pmol/min per mg), pcc C homozygotes (279±40 pmol/min per mg) and controls (273±37 pmol/min per mg).
Enzyme activity infibroblast extractsfrom heterozygotes. PCC activity in fibroblast extracts from controls and from obligate heterozygotes belonging to either the pcc A or pcc C complementation groups is shown in controls and homozygous affected individuals. This implies that there is generally no dosage compensation for autosomal mutations in human cells (12) . In accord with this gene dosage model, heterozygotes for the pcc A mutation have PCC activity in extracts of fibroblasts and leukocytes approximately half of that found in controls. Surprisingly, all heterozygotes for the pec C mutation had normal PCC activity in the two tissues studied. The prominent difference in residual PCC activity demonstrated between carriers for these two distinct pec mutations cannot be explained, as we stated above, by trivial differences in growth rate, passage number, or protein content of fibroblasts in culture. Moreover, because PCC assays with cell extracts from pcc A and pcc C homozygotes have shown that the Kms for all enzyme substrates are in the normal range (6), there is no reason to believe that the differences are simply a function of the in vitro assay conditions.
To our knowledge, there are only two other examples of autosomal recessively inherited enzyme deficiencies in man in which direct enzyme assay has yielded normal results in obligate carriers. Hamilton and Neel (13) reported that heterozygotes for one type ofacatalasemia had normal catalase activities in erythrocyte extracts. In a second, more recent instance, some heterozygotes in a family containing a proband with severe adenosine deaminase deficiency had adenosine deaminase activities in erythrocytes indistinguishable from that of controls, whereas other heterozygotes within the same family had activities distinctly below the normal range (14) . In neither instance was the mechanism of these unexpected findings provided.
Theoretically, the normal PCC activities in pcc C heterozygotes could reflect expression of either regulatory or structural gene mutations. However, we have shown recently that mutant PCC in cells from either pcc A or pcc C homozygotes is more labile to heat and cold than is normal PCC (6). Furthermore, mutant enzyme from pcc A (but not pcc C) cells has a reduced affinity for potassium activation. Given this evidence for different structurally altered PCC molecules in each mutant class, and, hence, for structural gene mutations, there is little reason to invoke mechanisms concerning regulatory genetic elements.
Critical interpretation of the present results requires detailed knowledge ofthe structure of PCC. Crystalline pig heart PCC has a mol wt of -700,000, and is composed of four identical protomers, each with a mol wt of -175,000 (15) . Although the subunit structure of PCC remains unclear, a recent preliminary observation suggests that protomers of the enzyme from bovine kidney are composed of two subunits of different molecular weight, the larger one containing the biotin moiety (16 Regardless of the molecular mechanism, the present results demonstrate that measurement of PCC activity in tissues from obligate heterozygotes provides independent, confirmatory evidence for the existence of the two distinct mutant classes defined by classic complementation analyses with somatic cell heterokaryons (5) . The failure to find a single family (of eight tested) in which a pcc A heterozygote married a pcc C heterozygote and produced an affected offspring is particularly noteworthy. Because there are no trivial explanations for this failure to identify symptomatic genetic compounds or double heterozygotes (such as a high incidence of consanguinity, or geographic and ethnic isolation), these results imply that in vivo (as well as in vitro) complementation is being observed in PCC deficiency.
Finally, these data emphasize that in certain disorders, such as PCC deficiency, measurement of enzyme activity will not identify all carriers in an unselected population. This conclusion must be borne in mind as we consider extension of carrier detection programs, such as those for Tay-Sachs and sickle cell disease, to other conditions.
